Solution for the hot spots in adaptive radiotherapy planning for cervical cancer: a case report and review of literature - Takeaways - MDSpire

Solution for the hot spots in adaptive radiotherapy planning for cervical cancer: a case report and review of literature

  • By

  • Peng Jiang

  • Xiang Wang

  • Shubao Cui

  • Chengyu Ren

  • Zilu Wang

  • Yongchun Zhang

  • Xiaoqian Wu

  • June 26, 2026

  • 0 min

Share

  • 1

    The Ethos system (version 2.0) is an online adaptive radiotherapy platform that automatically replans based on daily anatomical changes.

  • 2

    Hot spots in adaptive plans can occur due to the target's proximity to the multi-leaf collimator, limiting leaf movement and modulation.

  • 3

    The article presents a cervical cancer case where hot spots were identified during adaptive treatment, raising concerns about plan robustness.

  • 4

    An improved online ART workflow is proposed to correct target deviations and reduce hot spot risks in adaptive plans.

  • 5

    This study aims to enhance the quality and safety of adaptive radiotherapy for cervical cancer by addressing dosimetric uncertainties.

Original Source(s)

Solution for the hot spots in adaptive radiotherapy planning for cervical cancer: a case report and review of literature

  • by Peng Jiang, Xiang Wang, Shubao Cui, Chengyu Ren, Zilu Wang, Yongchun Zhang, Xiaoqian Wu

  • June 26, 2026

Related Content

ESMO Breast Cancer 2026 Highlights: Saci-IO HR+

Harold Burstein, MD, PhD, and Ana C. Garrido-Castro, MD discuss results from the Saci-IO HR+ trial, which were presented at the 2026 ESMO Breast Cancer Congress.

  • June 26, 2026

  • 1 min
Biopharma Vital Signs – Part 2: Emerging Trends

Industry experts discuss the trends reshaping biotech and biopharma development – from complex modalities and manufacturing pressures to AI, funding constraints, and the growing need to plan for commercialization earlier

  • June 26, 2026

  • 10 min
Intravoxel incoherent motion combined with conventional MRI for the differentiation of benign, intermediate, and malignant fibrous soft-tissue tumors